本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Benitec Biopharma Limited

13.64
+0.05000.37%
盤後13.640.00000.00%16:05 EDT
成交量:1.72萬
成交額:23.31萬
市值:3.48億
市盈率:-7.05
高:13.82
開:13.61
低:13.16
收:13.59
資料載入中...
2024/10/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/05

重要事件披露

Form 8-K - Current report
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/01

重要事件披露

Form 8-K - Current report
2024/05/24

SEC問詢函

Form CORRESP - Correspondence
2024/05/16

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/29

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/04/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/04/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/08

重要事件披露

Form 8-K - Current report
2024/03/02

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]